Patent · US Expired

PSCA: prostate stem cell antigen and uses thereof

US6881822B2 · kind B2 · utility

14Cited by

1References

16Claims

0Family size

Assignees

Latency, LLC · US
The Regents of the University of California · US

Inventors

Robert E. Reiter · Los Angeles, US
Owen N. Witte · West Hollywood, US
Arthur B. Raitano · Los Angeles, US

Key dates

Filing date	May 14, 2001
Grant date	Apr 19, 2005
Priority date	—
Expiry date	May 14, 2021

Classification

Technology area (CPC G)Physics
CPC primaryG01N2333/705
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention provides a novel prostate cell-surface antigen, designated Prostate Stem Cell Antigen (PSCA), which is widely over-expressed across all stages of prostate cancer, including high grade prostatic intraepithelial neoplasia (PIN), androgen-dependent and androgen-independent prostate tumors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.